The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) is focused on the development and commercialization of KETARX™ (Ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, ...
In the face of tough competition from Apellis and a recent setback with prescribers, Astellas’ geographic atrophy (GA) med ...
The Trump administration is being urged to shut down two controversial, NYC-government approved “safe injection sites” — ...
Hims & Hers hit the bullseye with its Super Bowl ad—it sparked a lot of attention from consumers. | Hims & Hers hit the ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...
It’s been three months since California voters overwhelmingly approved Proposition 36, a new law that pledged to provide ...
In response to complaints made publicly by the Partnership for Safe Medicine and the Obesity Society, Hims & Hers provided ...
Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment ...
A group of Senators has warned the FDA about an ad expected to air during Sunday’s big game that they believe misleads ...
Hims & Hers Health is set to have a commercial air during Super Bowl LIX. It’s already courting controversy, with calls to bar the game’s host, Fox, from broadcasting it. Why? Experts, advocates and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results